SOLUTIONS FOR AI BUILDERS · SAMD · BIOPHARMA

Access granted. But the data is far from decision-ready.

70% of healthcare AI POCs fail before production. Even the 20% of data you can access after months of gating hits Lock 2: the Knowledge, Fitness, Completeness, and Credibility gaps.

3–12 mo
Knowledge Gap

“Does this cohort contain the signal you need?” Months pass before the answer is no.

3–6 mo
Fitness Gap

“Is it structured and AI-ready?” Operational burn before a model can touch it.

3–12 mo
Completeness Gap

“Are all modalities complete?” Confidence collapses without longitudinal follow-up.

Days
The Fidalia Path

Collapses 3–11+ months of IRB / DUA delay into a certified, AI-ready Digital Cohort.

SOLUTION 01 · HALE™ (THE DATA LAYER FOR AUTONOMOUS HEALTH SYSTEMS)

No single silo is complete. Together they are more than the sum.

Autonomous diagnostic agents and continuous-learning clinical models need a live data mobility layer—not static single-hospital exports.

01 · POOLED TRUTH
Complementary Completeness

What Site A lacks, Site B supplies. The pool is structurally more complete than any single source.

02 · BUILT-IN DIVERSITY
Global Representation

Adds representation from APAC, India, Middle East, and EU—where data is generated but never shared.

03 · RAPID ACCESS
Days vs. 3–11 Mo IRB / DUA

Earlier go/no-go signal, earlier pivot, and continuous validation for human & agentic teams.

04 · PRIVACY BAKED IN
97.3 Clinical Fidelity

Zero patient records exposed, zero consent bottlenecks, and longitudinal clinical realism.

SOLUTION 02 · DATA TUNE (CURATION & INDEPENDENT EVALUATION)

We partner to source, connect, and curate clinical data—so your team can focus on the science.

01

Privacy-Safe, Context-Rich Data

Compliant without stripping the temporal and clinical nuance AI needs to reason.

02

Cohorts Built for Your Model

Engineered for Feasibility, Post-Training, Fine-Tuning & RWE—not generic billing pipelines.

03

Evaluation That Holds Up

Tested against real clinical workflows and uncontaminated holdouts defensible in FDA submissions.

THREE ENGAGEMENT PROFILES · MAPPED TO WHAT YOU BRING
01 · SOURCE

You have a defined use case and a preferred hospital or biobank in mind. We onboard them to HALE™ and curate end-to-end.

Start a SOURCE Conversation →
02 · SCALE (Most Popular)

You have a defined use case but no data partner identified. We source optimal multi-site suppliers and deliver your cohort.

Scope a SCALE Cohort →
03 · ENTERPRISE

Multiple programs across therapeutic areas. Dedicated node capacity, preferred access, and co-designed roadmap.

Schedule an Enterprise Briefing →
FOR AI BUILDERS · COHORT & EVALUATION FORM

Find the right healthcare data for your AI.

Tell us about the clinical, sensor, or imaging cohort your model needs. Our team will map matching health system nodes and scope a 50–100 patient Hero Slice prototype.

100% Healthcare Modalities

Longitudinal EHR (Epic, Cerner, MEDITECH), physiological sensors & telemetry waveforms, diagnostic DICOM imaging, whole-slide pathology, and multi-omics.

Routes directly to info@fidalia.ai
MODEL BUILDER INQUIRY

Scope a Healthcare Cohort or Evaluation

→ info@fidalia.ai